Raltegravir Tablets Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Raltegravir Tablets are antiviral medicines used for HIV infection treatment, viral suppression management, and combination antiretroviral therapy protocols in long-term HIV care programs.

The formulation contains Raltegravir, an integrase strand transfer inhibitor that blocks HIV integrase enzymes responsible for viral DNA integration into host immune cells, thereby interrupting HIV replication and viral multiplication pathways. The medicine is frequently utilized in combination antiviral treatment regimens for HIV management.

Genliva Wellness LLP manufactures these formulations as a Raltegravir Tablets Manufacturer in India, supplying antiretroviral medicines for institutional healthcare providers, government HIV treatment programs, pharmaceutical distributors, contract manufacturing companies, and regulated export-focused antiviral markets.

Raltegravir Tablets are formulated for integrase inhibitor antiviral therapy.

Oral antiretroviral tablet formulation
Frequently utilized in HIV treatment regimens
Integrase inhibitor antiviral activity profile
Optimized oral tablet administration
Manufactured using quality pharmaceutical ingredients
Intended for long-term antiviral therapy programs

This formulation is prescribed in HIV infection management.

Treatment of HIV infection
Management of viral suppression therapies
Administered in combination antiretroviral regimens
Utilized in long-term HIV care protocols
Helps control HIV replication pathways
Frequently selected in antiviral treatment programs

Raltegravir Tablets deliver integrase inhibitor antiviral therapy for HIV management.

Valuable in antiretroviral treatment programs
Frequently preferred in HIV viral suppression care
Convenient oral antiviral administration
Useful in long-term HIV management therapies
Effective integrase inhibitor antiviral support
Maintains reliable antiviral therapeutic performance